Preparation and characterization of silymarin synchronized-release microporous osmotic pump tablets

about

Preparation and characterization of silymarin synchronized-release microporous osmotic pump tablets

Item

http://www.wikidata.org/entity/Q36551090

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Preparation and characterizati ...... croporous osmotic pump tablets

@ast

Preparation and characterizati ...... croporous osmotic pump tablets

@en

type

Item

label

Preparation and characterizati ...... croporous osmotic pump tablets

@ast

Preparation and characterizati ...... croporous osmotic pump tablets

@en

prefLabel

Preparation and characterizati ...... croporous osmotic pump tablets

@ast

Preparation and characterizati ...... croporous osmotic pump tablets

@en

P1476

Preparation and characterizati ...... croporous osmotic pump tablets

@en

P2093

Ai-wen Huang

http://www.w3.org/2001/XMLSchema#string

Hong-tao Song

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Qi-ping Zeng

http://www.w3.org/2001/XMLSchema#string

Zhi-hong Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Synergy and other interactions in phytomedicines.

Preparation of silymarin proliposome: a new way to increase oral bioavailability of silymarin in beagle dogs.

A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos).

Herbal medicine in the treatment of liver diseases.

Hepatoprotective effect of commercial herbal extracts on carbon tetrachloride-induced liver damage in Wistar rats.

Osmotic micropumps for drug delivery.

Silymarin encapsulated poly(D,L-lactic-co-glycolic acid) nanoparticles: a prospective candidate for prostate cancer therapy.

Importance of novel drug delivery systems in herbal medicines.

Role of pharmacokinetics and metabolism in drug discovery and development.

Protective effect of silymarin during coronary artery bypass grafting surgery.

P304

519-531

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S91571

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26889080

http://www.w3.org/2001/XMLSchema#string

P932

4743634

http://www.w3.org/2001/XMLSchema#string